Controlling Diabetes - References

1. Anderson JW, Randles KM, Kendall CW, et al."Carbohydrate and fiber recommendations for individuals with diabetes: A quantitative assessment and meta-analysis of the evidence." J Am Coll Nutr23:5-17, 2004.

2. Wu T et al. "Effect of Multivitamin and Mineral Supplement on Infection and Quality of Life." Annals of Internal Medicine. 138, 5:365-71, 2003.

3. Montonen J et al. "Whole-grain and fiber intake and the incidence of type 2 diabetes." American Journal of Clinical Nutrition. 77, 3:622-9, 2003.

4. Weickert MO et al. "Cereal fiber improves whole-body insulin sensitivity in overweight and obese women." Diabetes Care. 29, 4:775-80, 2006.

5. Hodge AM et al. "Glycemic index and dietary fiber and the risk of type 2 diabetes." Diabetes Care. 27, 11:2701-6, 2004.

6. Tapola N et al. "Glycemic responses of oat bran products in type 2 diabetic patients." Nutrition, Metabolism and Cardiovascular Diseases. 15, 4:255-61, 2005.

7. Pick ME et al. "Oat bran concentrate bread products improve long-term control of diabetes, a pilot study." J Am Diet Assoc. 96, 12:1254-61, 1996.

8. Saltzman E et al. "An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women." Journal of Nutrition. 131, 5:1465-70, 2001.

9. Anderson RA. "Chromium in the prevention and control of diabetes." Diabetes Metab. 26, 1:22-7, 2000.

10. Martin J et al. "Chromium picolinate attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes." Diabetes Care. 29, 8:1826-32, 2006.

11. Vladeva SV, Terzieva DD, Arabadjiska DT. "Effect of chromium on the insulin resistance in patients with type II diabetes mellitus." Folia Med (Plovdiv). 47, 3-4:59-62, 2005.

12. Ghosh D et al. "Role of chromium supplementation in Indians with type 2 diabetes mellitus." J Nutr Biochem. 13, 11:690-97, 2002.

13. N Kleefstra et al. "Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized double-blind, placebo-controlled trial." Diabetes Care 29:521–25, 2006.

14. Lopez-Ridaura R et al. "Magnesium intake and the risk of type 2 diabetes in men and women." Diabetes Care. 27, 1:134-40, 2004.

15. He K et al. "Magnesium intake and incidence of metabolic syndrome among young adults." Circulation. 113, 13:1675-82, 2006.

16. Song Y et al. "Effects of oral magnesium supplementation on glycemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials." Diabet Med. 23, 10:1050-6, 2006.

17. Mehdi MZ et al. "Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium." Cell Biochem Biophys. 44, 1:73-81, 2006.

18. Halberstam M et al. "Oral vandyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic patients." Diabetes. 45, 5:659-66, 1996.

19. Urban J, Antonowicz-Juchniewicz J, Andrzejak R. "Vandium: threat and hope." Med Pr. 52, 2:125-33, 2001.

20. Srivastava AK. "Anti-diabetic and toxic effects of vanadium compounds." Mol Cell Biochem. 206, 1-2:177-82, 2000.

21. Hodgson JM et al. "Coenzyme Q10 improves blood pressure and glycemic control: a controlled trial in subjects with type 2 diabetes." Eur J Clin Nutr. 56, 11:1137-42, 2002.

22. Watts GF et al. "Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes mellitus." Diabetologia. 45, 3:420-6, 2002.

23. Konrad D. "Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation?" Antioxid Redox Signal. 7, 7-8:1032-9, 2005.

24. Ametov AS et al. "The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYNDNEY trial." Diabetes Care. 26, 3:770-6, 2003.

25. Morcos M et al. "Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria with diabetes mellitus: an exploratory study." Diabetes Res Clin Pract. 52, 3:175-83, 2001.

26. Annida B, Stanley Mainzin Prince P. "Supplementation of fenugreek leaves reduces oxidative stress in streptozotocin-induced diabetic rats." J Med Food. 8, 3:385-5, 2005.

27. Mondal DK et al. "Effect if fenugreek seeds on the fasting blood glucose level in the streptozotocin induced diabetic rats." Mymensingh Med J. 13, 2:161-4, 2004.

28. Khan et al. "Cinnamon improves glucose and lipids of people with type 2 diabetes." Diabetes Care. 26, 12:3215-8, 2003.

29. Mang B et al. "Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2." Eur J Clin Invest. 36, 5:340-4, 2006.

30. Vanschoonbeek K et al. "Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients." J Nutr. 136, 4:977-80, 2006.

31. van Dam RM, Feskens EJ. "Coffee consumption and risk of type 2 diabetes

mellitus." Lancet. 360:1477-8, 2002.

32. Hiroyasu I et al. "The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults." Ann Int Med. 144, 8:554-62, 2006.

33. Tanaka M et al. "Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds." Biol Pharm Bull. 29, 7:1418-22, 2006.

34. Bunyapraphatsara N et al. "Antidiabetic activity of aloe vera L. juice II. Clinical trials in diabetes mellitus patients in combination with glibenclamide." Phytomedicine. 3, 3:245-48, 1996.

35. Ananthan R. et al. "Modulatory effects of Gymnema montanum leaf extract on alloxan-induced oxidative stress in Wistar rats." Nutrition. 20, 3:280-5, 2004.

36. Ananthan R et al. "Effect of Gymnema montanum on blood glucose, plasma insulin and carbohydrate metabolic enzymes in alloxan-induced diabetic rats." J Med Food. 6, 1:43-9, 2003.

37. Ananthan R et al. "Antidiabetic effect of Gymnema montanum leaves: effect on lipid peroxidation induced oxidative stress in experimental diabetes." Pharmacol Res. 48, 6:551-6, 2003. 

38. Xie JT et al. "Anti-diabetic effects of Gymnema yunnanense extract." Pharmacol Res. 47, 4:323-9, 2003.

39. Shetty AK et al. "Effect of bitter gourd (Momordica charantia) on glycemic status in streptozotocin induced diabetic rats." Plant Foods Hum Nutr. 60, 3:109-12, 2005.

40. Ahmad N et al. "Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients." Bangladesh Medical Research Council Bulletin. 25, 1:11-3, 1999.

41. Kim JI et al. "Effects of pinitol isolated from soybeans on glycemic control and cardiovascular risk factors in Korean patients with type 2 diabetes mellitus: a randomized controlled study." European Journal of Clinical Nutrition. 59, 3:456-8, 2005.

42. Davis A et al. "Effect of pinitol treatment on insulin action in subjects with insulin resistance." Diabetes Care. 23, 7:1000-5, 2000.

43. Liu X. "Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type 2." Life Sci. 75, 21:2505-13, 2004.

44. Spadea L, Balestrazzi E. "Treatment of vascular retinopathies with Pycnogenol." Phytother Res. 15, 3:219-23, 2001.

45. Belcaro G. "Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol." Clin Appl Thromb Hemost. 12, 3:318-23, 2006.

46. Horio H et al. "Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats." Journal of Nutritional Science and Vitaminology. 47, 1:57-63, 2001.

47. Kubo K et al. "Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). I." Biol Pharm Bull. 17, 8:1106-10, 1994.